The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An analysis of a first-in-human study of NEXI-001 donor-derived antigen-specific CD8+ T-cell treatment of relapsed AML after allogeneic hematopoietic cell transplantation (HCT).
 
Monzr M. Al Malki
Consulting or Advisory Role - CareDX; Gilead/Forty Seven; Incyte; NexImmune
Research Funding - Gilead/Forty Seven; Incyte; NexImmune; Stemline Therapeutics
 
Sumithira Vasu
Consulting or Advisory Role - Johnson and Johnson; Omeros
Research Funding - Sanofi (Inst)
 
Dipenkumar Modi
Consulting or Advisory Role - AstraZeneca (I); Genentech (I); MorphoSys; Seagen
Speakers' Bureau - BeiGene
Research Funding - ADC Therapeutics; Genentech; Karyopharm Therapeutics
Expert Testimony - AstraZeneca
 
Suzanne D Afonso-Smith
Employment - NexImmune
Stock and Other Ownership Interests - NexImmune
Travel, Accommodations, Expenses - NexImmune
 
Sojung Kim
Employment - NexImmune
Stock and Other Ownership Interests - NexImmune
Patents, Royalties, Other Intellectual Property - NexImmune
 
Emily Lu
Employment - NexImmune
Stock and Other Ownership Interests - NexImmune
Patents, Royalties, Other Intellectual Property - NexImmune
 
Guido Marcucci
Stock and Other Ownership Interests - Ostentus Therapeutics
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie
Speakers' Bureau - Abbvie
Research Funding - Ostentus Therapeutics (Inst)
 
Mathias Oelke
Employment - NexImmune
Leadership - NexImmune
Stock and Other Ownership Interests - NexImmune
Patents, Royalties, Other Intellectual Property - Johns Hopkins University
 
Robert D. Knight
Employment - NexImmune
Leadership - NexImmune
Stock and Other Ownership Interests - NexImmune
Travel, Accommodations, Expenses - NexImmune
 
Juan Carlos Varela
Stock and Other Ownership Interests - NexImmune
Consulting or Advisory Role - NexImmune
Speakers' Bureau - Kite, a Gilead company